PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Journal of Dermatological Treatment2 citationsOpen Access

Management of adult vitiligo: approved topical JAK inhibitor and standard therapies

View Full Paper
MGMaria Elisabetta GrecoFFFrancesca FeresinADA. Di

Key Points

  • To evaluate the management strategies for adult vitiligo, focusing on topical JAK inhibitors and standard therapies.
  • Review of current therapies for vitiligo
  • Analysis of systemic regimens and their efficacy
  • Assessment of treatment selection criteria based on individual patient factors
  • Topical JAK inhibitors show promise in treatment
  • Individualized treatment selection improves outcomes
  • Efficacy of systemic therapies varies by patient characteristics

Abstract

Systemic regimens show benefits in selected clinical scenarios, although supporting evidence remains heterogeneous. Treatment selection should be individualized based on disease activity, extent, anatomical site, and patient preferences.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Greco et al. (2026) studied this question.

synapsesocial.com/papers/6996a7d3ecb39a600b3edda7https://doi.org/10.1080/09546634.2026.2627721
Ask AI
Helpful
Bookmark
Share
View Full Paper